Engineering major, Siemens, reported an 8% increase in topline to Rs 9,877 m for 9mFY04. For the quarter ended 30th June 2003, net sales declined marginally.
Operating Profit (EBDIT)
Operating Profit Margin (%)
Interest income (net)
Extra ordinary income
Profit before Tax
Profit after Tax/(Loss)
Net profit margin (%)
No. of Shares (eoy) (m)
Diluted Earnings per share (Rs)*
The major contributors to the sales turnover were automation & drives, power and healthcare businesses. Except power and real estate, other segments have shown a healthy growth. But since power is one of the major contributors, decline in its revenues for this quarter is a cause of concern. Power business is contract based so revenues are accounted only after the completion of the projects and management is confident that it will be able to make-up for the loss of revenues in the future. Moreover, if we look at the nine months results, the picture does not seem as bad. Though revenues for power segment have gone down by 12% but PBIT margins have improved from 3% to 4.7% (excluding extraordinary earnings from forfeiture of contract money) during 9mFY04.
Information and communication
Automation & Drives
Industrial solutions & services
Health care & other services
Automation, transport and information & communication segments have shown significant growth in revenues in this quarter as well as over the nine-month period. The PBIT margins for information & communication segment have gone down but for automation they have doubled from 2.1% to 4.8%. For transportation business it has marginally improved from 15.5% to 16.3%. Automation business has perked up for the industry as a whole, as user industries are opting for smart and intelligent devices to run the systems.
The operating income for 9 months FY04 rose by 7% YoY. However, the net profit for the period was up 49% largely led by extraordinary earnings. Excluding the extraordinary component, growth in profit before tax get pruned to 11% YoY. PBT for quarter ended June 30, 2003 was Rs 206 m as against Rs 216 m in the corresponding quarter of the previous year. The marginal dip of 5% is on account of some planned additional one-time costs booked in the current quarter against the healthcare business, which was not reflected in the previous quarter.
The new order inflow of the company stood at Rs 11,805 m for the nine months ended June 2003, registering a substantial rise of 38% YoY. The new order inflow for the quarter ended June 2003 was Rs 3,920 m, registering a growth of 55% YoY.
Looking at this, we can say that the slight dip in topline for the quarter is temporary because the orderbook is looking strong. Unexecuted orders stood at Rs 8,347 m at the end of June 2003, which is 85% of 9mFY04 revenues. Though the financials for the June quarter donít look too impressive, on a consolidated nine-month period the company looks in better shape. At Rs 350 the stock trades at a P/E of 10x its annualised 9mFY04 earnings. However, excluding extraordinary income, the P/E works out to be 16.9x annualised 9mFY04 earnings.
LEGAL DISCLAIMER: Equitymaster Agora Research Private Limited (hereinafter referred as 'Equitymaster') is an independent equity research Company. Equitymaster is not an Investment Adviser. Information herein should be regarded as a resource only and should be used at one's own risk. This is not an offer to sell or solicitation to buy any securities and Equitymaster will not be liable for any losses incurred or investment(s) made or decisions taken/or not taken based on the information provided herein. Information contained herein does not constitute investment advice or a personal recommendation or take into account the particular investment objectives, financial situations, or needs of individual subscribers. Before acting on any recommendation, subscribers should consider whether it is suitable for their particular circumstances and, if necessary, seek an independent professional advice. This is not directed for access or use by anyone in a country, especially, USA or Canada, where such use or access is unlawful or which may subject Equitymaster or its affiliates to any registration or licensing requirement. All content and information is provided on an 'As Is' basis by Equitymaster. Information herein is believed to be reliable but Equitymaster does not warrant its completeness or accuracy and expressly disclaims all warranties and conditions of any kind, whether express or implied. Equitymaster may hold shares in the company/ies discussed herein. As a condition to accessing Equitymaster content and website, you agree to our Terms and Conditions of Use, available here. The performance data quoted represents past performance and does not guarantee future results.
SEBI (Research Analysts) Regulations 2014, Registration No. INH000000537.
Equitymaster Agora Research Private Limited. 103, Regent Chambers, Above Status Restaurant, Nariman Point, Mumbai - 400 021. India. Telephone: +91-22-61434055. Fax: +91-22-22028550. Email: firstname.lastname@example.org. Website: www.equitymaster.com. CIN:U74999MH2007PTC175407